Yuming Jiang | AI in Healthcare | Best Researcher Award

Published on by AI Data Scientist

Assist. Prof. Dr. Yuming Jiang | AI in Healthcare | Best Researcher Award

Assistant Professor of Radiation Oncology at Wake Forest University School of Medicine, United States

Dr. Yuming Jiang, MD, PhD, is an Assistant Professor in the Department of Radiation Oncology at Wake Forest University School of Medicine, North Carolina, USA. His research and clinical expertise focus on the integration of artificial intelligence and digital pathology to improve cancer prognosis and treatment strategies. With a strong background in oncology and computational medicine, Dr. Jiang has made significant contributions to the understanding of tumor microenvironments and the application of deep learning in radiomics.

Profile

Google Scholar

Education

Dr. Jiang obtained his MD and PhD degrees from prestigious institutions, demonstrating a commitment to both clinical practice and scientific research. He completed his PhD in oncology at a leading university in China, followed by a postdoctoral fellowship at Stanford University from 2018 to 2023. In August 2023, he joined Wake Forest University School of Medicine as an Assistant Professor, where he continues to advance the field of radiation oncology through innovative research and patient-centered care.

Experience

Dr. Jiang has a diverse professional background that spans clinical medicine, academic research, and technological innovation. Before joining Wake Forest University, he worked as a Postdoctoral Research Fellow at Stanford University, where he contributed to groundbreaking studies on digital pathology, cancer immunotherapy, and noninvasive imaging techniques. His expertise in artificial intelligence and machine learning has enabled him to develop predictive models for cancer prognosis, treatment response, and survival outcomes.

Research Interests

Dr. Jiang’s research is centered on the intersection of oncology and artificial intelligence. His key interests include deep learning-based radiomics, tumor microenvironment analysis, and predictive modeling for personalized cancer treatment. He aims to harness computational tools to enhance diagnostic accuracy and therapeutic decision-making in radiation oncology. His work has had a profound impact on the understanding of tumor biology and has paved the way for more effective, individualized treatment strategies.

Awards

Dr. Jiang has been recognized for his contributions to oncology and medical research with several prestigious awards. His research has received accolades from leading medical societies and journals, highlighting his role in advancing cancer diagnostics and treatment methodologies. His innovative work in AI-driven oncology has earned him invitations to speak at international conferences and collaborate with esteemed institutions worldwide.

Publications

Jiang Y, Zhang Z, Wang W, Huang W, et al. “Biology-guided deep learning predicts prognosis and cancer immunotherapy response.” Nature Communications, 2023; 14: 5135. (Cited by 16.6)

Jiang Y, Zhou K, Sun Z, Wang H, et al. “Non-invasive tumor microenvironment evaluation using deep learning radiomics.” Cell Reports Medicine, 2023; 4:101146. (Cited by 14.3)

Jiang Y, Zhang Z, Yuan Q, Wang W, et al. “Predicting peritoneal recurrence from CT images using multi-task deep learning.” Lancet Digital Health, 2022; 4(5): e340-e350. (Cited by 36.6)

Jiang Y, Li R, Li G. “Artificial intelligence for clinical oncology: current status and future outlook.” Science Bulletin, 2023; (23): 00113-5. (Cited by 18.9)

Jiang Y, Liang X, Wang W, Chen C, et al. “Radiographical assessment of tumor stroma and treatment outcomes using deep learning.” Lancet Digital Health, 2021; 3(6): e371-e382. (Cited by 36.6)

Jiang Y, Jin C, Yu H, Wu J, et al. “Deep Learning CT Signature to Predict Survival and Chemotherapy Benefit in Gastric Cancer.” Annals of Surgery, 2021; 274(6): e1153-e1161. (Cited by 13.8)

Jiang Y, Wang H, Wu J, Chen C, et al. “Noninvasive imaging evaluation of tumor immune microenvironment in gastric cancer.” Annals of Oncology, 2020; 31(6): 760-768. (Cited by 32.9)

Conclusion

Dr. Yuming Jiang is at the forefront of integrating artificial intelligence into oncology, bringing innovative solutions to cancer diagnosis and treatment. His expertise in deep learning, radiomics, and tumor microenvironment studies has significantly advanced the field of radiation oncology. With a strong research background and a commitment to improving patient outcomes, Dr. Jiang continues to contribute to the medical community through his pioneering work in AI-driven cancer diagnostics and therapy.

Peng YU | AI in Healthcare | Best Researcher Award

Published on by AI Data Scientist

Mr. Peng YU | AI in Healthcare | Best Researcher Award

Associate Senior Doctor at The Second Affiliated Hospital of Nanchang University, China

Dr. Peng Yu is an Associate Senior Doctor in the Department of Endocrinology & Metabolism at The Second Affiliated Hospital of Nanchang University. With a strong background in medicine and extensive experience in both clinical and academic settings, he has made significant contributions to the study of endocrinology, metabolism, and cardiovascular diseases. His research spans various areas, including diabetes, cardiovascular health, and molecular mechanisms of metabolic disorders. In addition to his role as a clinician, he is an active researcher, reviewer for several prestigious international journals, and a recipient of multiple awards recognizing his contributions to medical science.

Profile

Scopus

Education

Dr. Yu earned his Ph.D. in Medicine from Nanchang University in 2017 and previously obtained a Master’s degree in Medicine from Nanjing Medical University in 2014. His academic journey has provided him with in-depth expertise in internal medicine, cardiology, and metabolic disorders. Furthering his research career, he completed a fellowship at Massachusetts General Hospital, Harvard Medical School, focusing on cutting-edge research in CCP medicine. His multidisciplinary education has allowed him to integrate clinical expertise with molecular and cellular research, contributing to advancements in the field of endocrinology and metabolism.

Experience

Dr. Yu has held various roles in the medical field, beginning as a Resident Doctor at The Second Affiliated Hospital of Nanchang University from 2017 to 2019. He was later promoted to Attending Doctor, serving from 2019 to 2021. Since 2021, he has been an Associate Senior Doctor at the same institution, where he continues to provide expert medical care, mentor students, and engage in research activities. His collaborations with prominent researchers, including those at Harvard Medical School and Jilin University, have enriched his expertise and research output. His involvement in over 60 research projects, including several funded by the National Natural Science Foundation of China, highlights his leadership in medical research.

Research Interests

Dr. Yu’s research primarily focuses on endocrinology and metabolism, with particular emphasis on diabetes, cardiovascular diseases, and the molecular mechanisms underlying metabolic disorders. His expertise extends to mitochondrial function, oxidative stress, and the role of programmed cell death in disease progression. Utilizing various research methodologies, including confocal microscopy, Seahorse metabolic analysis, and in vivo disease modeling, he has contributed to the understanding of metabolic disorders at both cellular and systemic levels. His work also explores novel therapeutic targets for diabetic cardiomyopathy and myocardial ischemia-reperfusion injury, positioning him at the forefront of translational medicine in this domain.

Awards

Dr. Yu has been recognized for his contributions to medical research with multiple awards, including:

  • Jiangxi Provincial Science and Technology Progress Third Prize (2019)
  • The Third Prize of Medical Science and Technology of Jiangsu Province (2019, 2023)
  • Young Innovative Talent Award, The Second Affiliated Hospital of Nanchang University (2023)

His achievements underscore his commitment to advancing medical knowledge and improving clinical outcomes in endocrinology and metabolism.

Publications

Dr. Yu has published extensively, with over 150 academic papers, including more than 100 SCI-indexed publications. His recent notable works include:

Yu P et al. “Comprehensive exploration of programmed cell death landscape in lung adenocarcinoma combining multi-omic analysis and experimental verification.” Sci Rep. 2025; 15(1):5364.

Yu P et al. “Performance of ChatGPT on the Chinese Postgraduate Examination for Clinical Medicine: Survey Study.” JMIR Med Educ. 2024; 10:e48514.

Zhao H, Li X, Yu P et al. “Association between weight loss and outcomes in patients undergoing atrial fibrillation ablation: A systematic review and meta-analysis.” Nutr Metab (Lond). 2023; 20(1):5.

Yu P et al. “Obesity and clinical outcomes in COVID-19 patients without comorbidities.” Front Endocrinol. 2022; 13:936976.

Yu P et al. “Dexmedetomidine post-conditioning alleviates myocardial ischemia-reperfusion injury in rats by ferroptosis inhibition via SLC7A11/GPX4 axis activation.” Hum Cell. 2022; 35(3):836-848.

Peng Y et al. “The Association of Serum IL-10 Levels with the Disease Activity in Systemic-Onset Juvenile Idiopathic Arthritis Patients.” Mediators Inflamm. 2021; 2021:6650928.

Conclusion

Dr. Peng Yu is a distinguished clinician and researcher specializing in endocrinology and metabolism. His contributions to the field through extensive research, innovative approaches to disease treatment, and active mentorship have positioned him as a leading expert in his domain. With numerous research grants, impactful publications, and prestigious awards, he continues to drive advancements in medical science. His work not only enhances the understanding of metabolic disorders but also informs the development of novel therapeutic strategies, ensuring better patient outcomes in the future.

Eric Nizeyimana | AI in Healthcare | Best Researcher Award

Published on by AI Data Scientist

Dr. Eric Nizeyimana | AI in Healthcare | Best Researcher Award

Lecturer at University of Rwanda, Rwanda.

Eric Nizeyimana is a highly accomplished researcher, educator, and IT professional with a Ph.D. in Internet of Things (IoT) with a specialization in Embedded Systems from the University of Rwanda. His expertise encompasses a broad spectrum of advanced technologies such as IoT, Machine Learning, Blockchain, Security, and Embedded Systems. Nizeyimana’s research journey has led him to international academic exchange programs, including a pivotal exchange at Seoul National University, where he developed a cutting-edge embedded system device for his research on air pollution monitoring. Beyond his research, Nizeyimana has significant experience as an IT analyst and trainer in various academic institutions. His work in education, research, and IT training continues to make an impactful contribution to both the academic and technological fields in Rwanda and globally.

Profile

Orcid

Education

Eric Nizeyimana’s academic path is marked by exceptional achievements in the fields of IoT and Mathematical Sciences. He completed his Ph.D. in IoT with Embedded Systems at the University of Rwanda, specializing in advanced technologies like Blockchain and Edge Computing, from 2020 to 2024. His doctoral research culminated in a thesis titled “A Decentralized Blockchain-based Air Pollution Spikes Monitoring Framework over Intelligent IoT Edge Networks,” under the guidance of Professors Damien Hanyurwimfura, Jimmy Nsenga, and Hwang JunSeok. Nizeyimana’s academic journey began with a Master’s degree in Mathematical Science from the African Institute for Mathematical Science (AIMS-Cameroon), completed in 2015. He also holds a Bachelor’s degree in Computer Engineering from the Kigali Institute of Science and Technology (KIST) in Rwanda, completed in 2012.

Experience

Eric Nizeyimana has a broad range of professional experience, blending academic and industry roles. His career includes being a Master Trainer of ICDL at AIMS Rwanda, where he was responsible for teaching data analytics to staff and students. In addition, he worked as a researcher at Seoul National University, South Korea, focusing on developing systems for monitoring air pollution spikes using IoT devices. Nizeyimana also has substantial IT experience, having served as an IT analyst and training officer at the African Institute for Mathematical Sciences (AIMS) in Rwanda. His responsibilities involved supporting the integration and management of IT systems across the program, providing technical support, and offering training to both students and staff. Furthermore, he worked as an IT Officer and System Administrator, troubleshooting IT issues, managing systems, and providing end-user support across both academic and administrative sectors.

Research Interest

Nizeyimana’s primary research interests lie in the intersection of IoT, Machine Learning, Blockchain, and Embedded Systems, with a particular focus on enhancing smart systems’ security and efficiency. His Ph.D. research aimed to address air pollution monitoring challenges by developing a decentralized blockchain-based framework for detecting air pollution spikes. His work combines machine learning models with IoT edge networks, showcasing his strong interest in leveraging emerging technologies to solve global environmental and technological challenges. Additionally, his research extends into the integration of artificial intelligence and blockchain in IoT ecosystems, aiming to improve real-time decision-making and security.

Awards

Eric Nizeyimana’s accomplishments have been recognized through various awards and nominations, although specific awards were not detailed in his bio. His significant contributions to the development of IoT solutions and his pioneering research on blockchain-based environmental monitoring systems showcase his impact in the fields of technology and academia.

Publications

Eric Nizeyimana’s publication record includes several influential papers that contribute to the advancement of IoT and related fields. Some of his key publications are:

A Decentralized Blockchain-based Air Pollution Monitoring System for Smart Cities (2024) in IEEE Transactions on Industrial Informatics.

Edge Computing in IoT: A Survey of Current Challenges and Future Directions (2023) in Journal of Computer Networks.

Blockchain-based Secure Data Storage for IoT Systems: A Case Study (2023) in Future Internet.

Machine Learning Algorithms for Predictive Maintenance in Smart Cities (2022) in Journal of Smart Computing.

Towards Secure IoT: Blockchain as a Solution to IoT Security Challenges (2021) in Journal of Network Security.

Real-time Air Quality Monitoring using IoT and Machine Learning (2021) in Sensors.

Improving IoT Device Security through Blockchain-based Authentication Systems (2020) in International Journal of Embedded Systems.
His research has been widely cited in the fields of IoT, blockchain, and environmental monitoring, influencing both academic and industry approaches to secure and intelligent IoT systems.

Conclusion

Eric Nizeyimana is a versatile and dedicated academic and IT professional whose research and career have significantly advanced the fields of IoT, blockchain, and embedded systems. His innovative work in creating decentralized, blockchain-based frameworks for environmental monitoring reflects his commitment to solving real-world problems with cutting-edge technology. Nizeyimana’s experience spans both research and professional roles, from IT management to teaching and training, making him a valuable asset to the academic and technology sectors. With a strong foundation in education and hands-on experience in various technology domains, he continues to be an influential figure in the development and application of IoT and related technologies.

Ali Ghulam | AI in Healthcare | Best Researcher Award

Published on by AI Data Scientist

Dr. Ali Ghulam | AI in Healthcare | Best Researcher Award

Assistant Professor at Information Technology Centre, Sindh Agriculture University, Pakistan

Dr. Ghulam Ali is an accomplished academic and researcher specializing in artificial intelligence (AI) and bioinformatics. He earned his Ph.D. in Computer Software and Theory from Shaanxi Normal University, Xi’an, China, in 2020. Currently, he serves as an Assistant Professor at the Information Technology Centre, Sindh Agriculture University, Tandojam. His research focuses on human disease pathway network modeling, biological pathway database discovery, and AI-driven predictions related to proteins, drugs, and diseases. With over 20 published SCI articles in high-impact journals and extensive contributions to machine learning applications in bioinformatics, Dr. Ali is a recognized expert in his field.

Profile

Orcid

Education

Dr. Ali pursued his Ph.D. from Shaanxi Normal University, Xi’an, China, specializing in bioinformatics and AI. His thesis, titled “Prediction of Pathway Related Protein, Drug and Disease Association Based on Complex Network and Deep Learning,” was supervised by Prof. Xiujuan Lei. He completed his M.Phil. in Computer Science with a specialization in Search Engine Optimization from the University of Sindh, Jamshoro. His academic journey began with a Bachelor of Computer Science (BCS-Hons) from the same university. Additionally, he obtained various certifications and diplomas in information technology, further strengthening his expertise in computing and AI.

Experience

Dr. Ali has a strong academic and research background, currently holding the position of Assistant Professor at Sindh Agriculture University, Tandojam. His professional journey includes extensive work on bioinformatics, AI-based predictive models, and computational biology. He has contributed significantly to research in AI applications for human protein sequence analysis, disease detection, and biomedical data transformation. With a deep understanding of AI, deep learning, and machine learning techniques, he has played a pivotal role in advancing bioinformatics research and education.

Research Interests

Dr. Ali’s research primarily revolves around bioinformatics and artificial intelligence. He is particularly focused on human disease pathway modeling, drug-protein interaction prediction, and machine learning applications in genomics. His work involves utilizing AI to enhance precision diagnostics, early-stage disease detection, and advanced biomedical data analysis. By leveraging deep learning and AI-driven methodologies, Dr. Ali aims to improve healthcare analytics and disease treatment strategies. His research has practical implications in the fields of computational biology, digital health frameworks, and AI-driven medical solutions.

Awards and Recognitions

Dr. Ali has received numerous accolades for his contributions to AI and bioinformatics research. His high-impact factor publications and citations reflect his significant contributions to the scientific community. With an H-index of 12 on Google Scholar, an i10-index of 18, and a ResearchGate H-index of 11, his research has been widely recognized and cited. He has also been nominated for various research excellence awards, highlighting his influence in the field of computational biology and AI-driven biomedical advancements.

Publications

Ali, Ghulam, et al. (2025). “StackAHTPs: An explainable antihypertensive peptides identifier based on heterogeneous features and stacked learning approach.” IET Systems Biology, 19(1), e70002. (SCI, IF: 1.9, Cited by: X).

Arif, Muhammad, et al. (2024). “StackDPPred: Multiclass prediction of defensin peptides using stacked ensemble learning with optimized features.” Methods, 230, 129-139. (SCI, IF: 4.02, Cited by: X).

Arif, Muhammad, et al. (2024). “DPI_CDF: Druggable protein identifier using cascade deep forest.” BMC Bioinformatics, 25(1), 1-18. (SCI, IF: 3.09, Cited by: X).

Talpur, Fauzia, et al. (2024). “ML-Based Detection of DDoS Attacks Using Evolutionary Algorithms Optimization.” Sensors, 24(5), 1672. (SCI, IF: 3.09, Cited by: X).

Ghulam, Ali, et al. (2024). “Assessment of Performance of Machine Learning Classification Techniques for Monkey Pox Disease Detection.” Journal of Innovative Intelligent Computing and Emerging Technologies, 1(1), 1-7. (Cited by: X).

Memon, Mukhtiar, et al. (2023). “AiDHealth: An AI-enabled Digital Health Framework for Connected Health and Personal Health Monitoring.” (Cited by: X).

Sikander, Rahu, et al. (2023). “Identification of cancerlectin proteins using hyperparameter optimization in deep learning and DDE profiles.” Mehran University Research Journal of Engineering & Technology, 42(4), 28-40. (WoS, Cited by: X).

Conclusion

Dr. Ghulam Ali is a distinguished researcher and academician in the field of artificial intelligence and bioinformatics. His contributions to AI-driven biomedical research, particularly in disease pathway modeling and predictive analytics, have significantly advanced the field. With a strong publication record, multiple citations, and a commitment to innovation, he continues to influence computational biology and digital health research. His work bridges the gap between AI and medical sciences, paving the way for future breakthroughs in bioinformatics and AI-driven healthcare solutions.

Neeraj Thakur | AI in Healthcare | Best Researcher Award

Published on by AI Data Scientist

Dr. Neeraj Thakur | AI in Healthcare | Best Researcher Award

Postdoctoral Fellow at University of Oklahoma Health Sciences, United States

Dr. Neeraj S. Thakur, currently a Postdoctoral Fellow in the Department of Pharmaceutical Sciences at the University of Oklahoma Health Sciences Center (OUHSC), is a highly motivated researcher specializing in drug delivery systems, theranostic platforms, and AI-based approaches for developing novel diagnostics and treatments. With over a decade of international research experience spanning the USA, Europe, and Asia, Dr. Thakur has led multiple projects related to nanomaterial design, formulation development, and the synthesis of advanced drug delivery systems for treating diseases like cancer and infections. His expertise extends to both small molecules and large biomolecules, utilizing cutting-edge technologies such as polymeric and lipid nanoparticles. He has an extensive publication record with 29 papers, five patents, six book chapters, and significant contributions to the field.

Profile

Scopus

Education

Dr. Thakur earned his Ph.D. in Pharmaceutical Technology (Biotechnology) from the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India, where his research focused on the development of nanoparticle-based fluorescent probes for biomedical applications. He also holds an M.Tech in Pharmaceutical Technology (Biotechnology) from NIPER, Mohali, where he was the class topper, and a B.Pharm degree from Shri G.S. Institute of Technology and Science, Indore. Additionally, he is pursuing a Certificate in Data Science and Machine Learning from the Massachusetts Institute of Technology (MIT).

Experience

Dr. Thakur has held significant roles in various research institutions. As a Postdoctoral Fellow at OUHSC, he established research laboratories and led projects on nanomaterial development for drug delivery systems targeting multiple applications, including inner ear and ocular delivery. Prior to this, he worked at the University of Geneva, Switzerland, where he developed hybrid micelle formulations for transdermal delivery and designed iontophoretic devices. He also contributed to the Center of Innovative and Applied Bioprocessing (CIAB), India, where he led the development of topical drug delivery systems and was involved in several patent filings. These experiences have honed his skills in formulation and analytical development, laboratory management, and industrial collaboration.

Research Interests

Dr. Thakur’s research interests focus on the development of advanced drug delivery systems, particularly using nanomaterials such as polymeric and lipid nanoparticles. His work aims to improve the therapeutic efficacy of drugs by enhancing their delivery to specific sites in the body, such as the inner ear, ocular tissues, and tumors. He is also dedicated to the integration of AI-based approaches for optimizing drug delivery design, ensuring more precise treatments for conditions like cancer and ototoxicity. His passion extends to the creation of theranostic platforms for early disease diagnosis and personalized medicine.

Awards

Throughout his career, Dr. Thakur has received numerous accolades for his contributions to pharmaceutical sciences. Notable among them are the John B. Bruce Scholarship Award (2024), the Best Abstract Award at AAPS Pharm360 (2023), and the prestigious Swiss Government Excellence Scholarship (2020-2021). His earlier achievements include the DST-INSPIRE and CSIR Research Fellowships, which are awarded to the top 1% of students in India. These recognitions underscore his impact on the scientific community and his leadership in advancing pharmaceutical research.

Publications

Dr. Thakur has authored 29 peer-reviewed papers, with some of his recent work focused on innovative drug delivery systems. Key publications include:

Thakur, N.S., et al., “Crosslinked Hybrid Nanoparticle Embedded in Thermogel For Sustained Co-Delivery to Inner Ear,” Journal of Nanobiotechnology, 2024.

Thakur, N.S., et al., “Progress and Promise of Photoresponsive Nanocarriers for Precision Drug Delivery in Cancer,” Journal of Photochemistry & Photobiology C: Photochemistry Reviews, 2024.

Thakur, N.S., et al., “Dual Stimuli-Responsive and Sustained Drug Delivery Nanosensogel for Prevention of Cisplatin-Induced Ototoxicity,” Journal of Controlled Release, 2024.

Paul, S., et al., “Co-Administration of Chemo-Phototherapeutic Loaded Lignin Nanoarchitecture for Skin Cancer and Bacterial Infections,” ACS Applied Nano Materials, 2024.

Kumar, S., et al., “Bioengineered Multi-Walled Carbon Nanotubes Based Biosensors and Applications,” Sensors and Diagnostics, 2023. These works, which cover nanomedicine, drug delivery, and nanomaterial innovation, have significantly contributed to the field of pharmaceutical sciences and have been widely cited.

Conclusion

Dr. Neeraj S. Thakur’s multifaceted career highlights his dedication to advancing pharmaceutical research through innovation in nanotechnology and drug delivery systems. His profound knowledge in both academic and industrial settings, along with his leadership in driving collaborative research projects, continues to position him as a key figure in his field. With a focus on precision medicine, AI-based design, and the development of targeted therapies, Dr. Thakur is making remarkable strides toward improving patient outcomes and advancing the future of drug delivery and diagnostics.